Consistent with the findings of TC and TG, the combination of apoA-I and CIGB-258 displayed a substantial effect on elevating the HDL-C level impaired by CML (Figure 13C). The gene discussed is APOA1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.